{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T18:48:27Z","timestamp":1781722107160,"version":"3.54.5"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"vor","delay-in-days":66,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Pharmacology and Drug Discovery"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.crphar.2021.100021","type":"journal-article","created":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T11:17:34Z","timestamp":1616325454000},"page":"100021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Enhanced antihyperlipidemic potential of gemfibrozil under co-administration with piperine"],"prefix":"10.1016","volume":"2","author":[{"given":"S.","family":"Mohanalakshmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shvetank","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.K.","family":"Ashok Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.crphar.2021.100021_bib1","first-page":"407","article-title":"A\u00a0comprehensive review on antihyperlipidemic activity of various a comprehensive review on antihyperlipidemic activity of various medicinal plants","volume":"7","author":"Asija","year":"2016","journal-title":"Int. J. Curr. Pharm. Rev. Res."},{"key":"10.1016\/j.crphar.2021.100021_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2018.11.013","article-title":"Incidence of cardiovascular disease in familial combined hyperlipidemia: a 15-year follow-up study","volume":"280","author":"Luijten","year":"2018","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.crphar.2021.100021_bib4","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1172\/JCI111879","article-title":"Mechanism of action of gemfibrozil on lipoprotein metabolism","volume":"75","author":"Saku","year":"1985","journal-title":"J.\u00a0Clin. Invest."},{"issue":"13","key":"10.1016\/j.crphar.2021.100021_bib5","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/BF01667018","article-title":"Gemfibrozil absorption and elimination in kidney and liver disease","volume":"68","author":"Knauf","year":"1990","journal-title":"Klin. Wochenschr."},{"issue":"1","key":"10.1016\/j.crphar.2021.100021_bib6","first-page":"1","article-title":"Effect of piperine pn antihyperlipidemic activitiy and pharmacokinetic profile of simvastatin","author":"Venkatesh","year":"2019","journal-title":"Inven. Rapid Pharm. Pract."},{"key":"10.1016\/j.crphar.2021.100021_bib7","first-page":"90","article-title":"Indian herbal enhnacers: a review","volume":"3","author":"Singh","year":"2009","journal-title":"Phcog. Rev."},{"key":"10.1016\/j.crphar.2021.100021_bib8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3892\/etm.2014.1717","article-title":"Piperine potentiates the hypocholesterolemic effect of curcumin in rats fed on a high fat diet","volume":"8","author":"Tu","year":"2014","journal-title":"Exp. Ther. Med."},{"issue":"2","key":"10.1016\/j.crphar.2021.100021_bib9","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1128\/AAC.50.2.810-812.2006","article-title":"Piperine. A phytochemical potentiator of ciprofloxacin against Staphylococcus aureus","volume":"50","author":"Khan","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.crphar.2021.100021_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0021-9150(94)90128-7","article-title":"Comparative effects of gemfibrozil and clofibrate in type III hyperlipoproteinemia","volume":"106","author":"Larsen","year":"1994","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.crphar.2021.100021_bib11","first-page":"263","article-title":"Antidyslipidemic and antioxidant property of piperine","volume":"8","author":"Lakshmi","year":"2012","journal-title":"Nat. Prod. Ind. J."},{"issue":"2","key":"10.1016\/j.crphar.2021.100021_bib12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/bmc.1130050205","article-title":"Simultaneous determination of gemfibrozil and its metabolites in plasma and urine by a fully automated high performance liquid chromatographic system","volume":"5","author":"Nakagawa","year":"1991","journal-title":"Biomed. Chromatogr."},{"issue":"3","key":"10.1016\/j.crphar.2021.100021_bib13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/10826070500452051","article-title":"Simple and sensitive HPLC method for determination of gemfibrozil in human plasma with fluorescence detection","volume":"29","author":"Kim","year":"2006","journal-title":"J.\u00a0Liq. Chromatogr. Relat. Technol."},{"issue":"1","key":"10.1016\/j.crphar.2021.100021_bib14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0022-3565(25)20081-7","article-title":"Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism","volume":"232","author":"Atal","year":"1985","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"7","key":"10.1016\/j.crphar.2021.100021_bib15","first-page":"591","article-title":"Role of piperine as an effective bioenhancer in drug absorption","volume":"9","author":"Mhaske","year":"2018","journal-title":"Pharm. Anal. Acta"},{"issue":"6","key":"10.1016\/j.crphar.2021.100021_bib16","first-page":"568","article-title":"In vitro and in vivo inhibition of pulmonary cytochrome P450 activities by piperine, a major ingredient of piper species","volume":"29","author":"Reen","year":"1991","journal-title":"Indian J. Exp. Biol."},{"issue":"7","key":"10.1016\/j.crphar.2021.100021_bib17","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/0006-2952(92)90195-O","article-title":"Piperine-mediated changes in the permeability of rat intestinal epithelial cells. The status of gamma-glutamyl transpeptidase activity, uptake of amino acids and lipid peroxidation","volume":"43","author":"Johri","year":"1992","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.crphar.2021.100021_bib18","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1124\/dmd.107.017269","article-title":"The UDP-glucuronosyltransferase 2B7 isozyme is responsible for gemfibrozil glucuronidation in the human liver","volume":"35","author":"Mano","year":"2007","journal-title":"Drug Metab. Dispos."},{"issue":"13","key":"10.1016\/j.crphar.2021.100021_bib19","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/BF01667018","article-title":"Gemfibrozil absorption and elimination in kidney and liver disease","volume":"68","author":"Knauf","year":"1990","journal-title":"Klin. Wochenschr."},{"issue":"1","key":"10.1016\/j.crphar.2021.100021_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1124\/dmd.105.007633","article-title":"Glucuronidation converts gemfibrozil to a potent, metabolism-dependent inhibitor of CYP2C8: implications for drug-drug interactions","volume":"34","author":"Ogilvie","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.crphar.2021.100021_bib21","first-page":"1","article-title":"New nicotinic acid-based 3,5-diphenylpyrazoles: design, synthesis and antihyperlipidemic activity with potential NPC1L1 inhibitory activity","author":"Shoman","year":"2020","journal-title":"Mol. Divers."},{"key":"10.1016\/j.crphar.2021.100021_bib22","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/mnfr.200800517","article-title":"Choosing hamsters but not rats as a model for studying plasma cholesterol-lowering activity of functional foods","volume":"53","author":"Zhang","year":"2009","journal-title":"Mol. Nutr. Food Res."},{"issue":"3","key":"10.1016\/j.crphar.2021.100021_bib23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2165\/00003495-198836030-00004","article-title":"Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia","volume":"36","author":"Todd","year":"1988","journal-title":"Drugs"}],"container-title":["Current Research in Pharmacology and Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590257121000080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590257121000080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T04:49:29Z","timestamp":1762922969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590257121000080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":22,"alternative-id":["S2590257121000080"],"URL":"https:\/\/doi.org\/10.1016\/j.crphar.2021.100021","relation":{},"ISSN":["2590-2571"],"issn-type":[{"value":"2590-2571","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced antihyperlipidemic potential of gemfibrozil under co-administration with piperine","name":"articletitle","label":"Article Title"},{"value":"Current Research in Pharmacology and Drug Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crphar.2021.100021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100021"}}